CARsgen submits dual IND applications to China NMPA for allogeneic BCMA CAR-T product, CT0596: Shanghai, China Tuesday, December 30, 2025, 11:00 Hrs [IST] CARsgen Therapeutics Hol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback